BioAtlas: Reached a strategic partnership with Four Rings Medical Holdings Group Co., Ltd.

BioAtla announces that the company has reached a strategic cooperation with Sihuan Pharmaceutical Holdings Group Co., Ltd. Under the agreement, both parties will rely on BioAtla’s leading fully human antibody development platform, and, in combination with Sihuan Pharmaceutical’s extensive experience in drug development, manufacturing, and commercialization, carry out cooperation and exchange on innovative drug R&D in multiple disease areas such as weight loss. The parties will also work to achieve complementary advantages and synergistic resource allocation, thereby establishing a long-term and stable cooperative relationship.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin